Charles Perou Archives - UNC Lineberger Comprehensive Cancer Center

July 23, 2026

Medical Xpress: Test offers new way to personalize treatment, reduce unnecessary chemotherapy for patients with breast cancer

A technician positions a patient at an imaging machine to receive a mammogram.

A cancer diagnostic test developed by a group of researchers, including Charles Perou, PhD, has been found to accurately predict whether patients with breast cancer actually need chemotherapy – or if hormone therapy alone can put them on a path towards remission.

Perou received his honor at the conferment ceremony in Stockholm, Sweden.

UNC Lineberger's Charles Perou, PhD, was awarded the title of Honorary Doctor by Karolinska Institutet in Sweden in recognition of his groundbreaking contributions to breast cancer research.

Pink ribbon with research tools on a pink table.

A new clinical trial that adjusts treatment as breast cancer evolves is now open and enrolling patients at UNC Lineberger Comprehensive Cancer Center.

Attendees at a keynote session for the UNC Lineberger Data Science Symposium.

Researchers, clinicians, data scientists and trainees gathered for the inaugural UNC Lineberger Innovate Cancer Data Science Symposium, a daylong event highlighting the rapid evolution of AI, genomics and data‑driven tools shaping the future of cancer care.

Cluster of circulating tumor cells and white blood cells.

UNC Lineberger will lead the development of a next-generation clinical trial for metastatic breast cancer. The new trial design will adapt treatment plans in near real-time by analyzing changes in each patient’s cancer and matching it to the most promising therapy.

AACR (American Association for Cancer Research) Annual Meeting 2025 Chicago.

Nearly 30 UNC Lineberger and UNC faculty and trainees will present findings and participate during the American Association for Cancer Research annual meeting in Chicago, April 25-30.

More than 10,000 cancer researchers, clinicians and patient advocates from across the globe are expected to attend this year’s San Antonio Breast Cancer Symposium. The meeting will feature presentations by several UNC faculty members and trainees.

The San Antonio Breast Cancer Symposium features presentations outlining basic, translational, clinical and community-based study findings focused on advancing the prevention, diagnosis and treatment of breast cancer.

Headshots of the 12 UNC Lineberger members who are listed on Clarivate’s 2023 Highly Cited Researchers list.

Twelve UNC Lineberger Comprehensive Cancer Center members were named to Clarivate’s 2023 Highly Cited Researchers™ list, which recognized scientists who published papers that ranked in the top 1% of cited publications in their field between 2012-2022.

Tag: Charles Perou

Medical Xpress: Test offers new way to personalize treatment, reduce unnecessary chemotherapy for patients with breast cancer

Hormone therapy or chemotherapy? A test developed by a UNC researcher can tell you

Perou named Honorary Doctor by Karolinska Institutet

A new clinical trial for metastatic breast cancer opens

UNC Lineberger hosts inaugural Innovate Cancer Data Science Symposium

UNC Lineberger awarded up to $28M to develop an adaptive clinical trial for metastatic breast cancer

UNC Lineberger and UNC faculty and trainees present findings at AACR annual meeting

International breast cancer meeting features UNC Lineberger research

Cancer center researchers to present latest findings at international breast cancer meeting

UNC Lineberger faculty named world’s most highly cited researchers